A comprehensive guide from the American Medical Association (AMA), which includes information for those who want to support communities severely impacted by COVID-19, including the how and where to volunteer and all things to consider.

Steven A. Pergam, MD, Medical Director for Infection Prevention at Seattle Cancer Care Alliance (SCCA), provides insight on the unique challenges facing oncologists as they fight the COVID-19 pandemic.

Although researchers emphasized more research is necessary, a study in Blood Advances demonstrated that tocilizumab may be an effective treatment for patients with COVID-19 and hematologic malignancies.

Oncology healthcare providers must consider a trio of specific management strategies for their patients during this time, as COVID-19 can be particularly lethal in patients with cancer.

According to JAMA Oncology, researchers located in Wuhan, China – the epicenter of the COVID-19 outbreak – there were more coronavirus cases among patients with cancer versus the general public.

Despite a small sample size, a recent trial demonstrated hydroxychloroquine treatment’s effect reinforced by azithromycin is significantly associated with viral load reduction/disappearance in COVID-19 patients.